Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melanie Thompson

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Antiviral Therapy|December 7, 2016
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trialMelanie Thompson, Jacob P Lalezari, Richard Kaplan, et al.
AIDS Patient Care and Stds|July 17, 2008
Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIVLytt I Gardner, Gary Marks, Christine M O'Daniels, et al.
AIDS (London, England)|January 28, 2006
Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjectsMelanie Thompson, Edwin DeJesus, Gary Richmond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2019
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety AnalysisMelanie Thompson, Chloe Orkin, Jean-Michel Molina, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|February 27, 2009
Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPsMark Thrun, Paul F Cook, Lucy A Bradley-Springer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2013
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United StatesAlbert Y Liu, Eric Vittinghoff, Kata Chillag, et al.
AIDS and Behavior|September 19, 2009
Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and womenCarol Golin, Gary Marks, Julie Wright, et al.
AIDS (London, England)|December 31, 2008
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trialCalvin J Cohen, Daniel S Berger, Gary Blick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Factors that complicate the treatment of tuberculosis in HIV-infected patientsMark S Dworkin, Michael R Adams, David L Cohn, et al.
Journal of the International AIDS Society|November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsJosep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Antiviral Therapy|December 7, 2016
Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in antiretroviral-experienced subjects: week 48 analysis of AI438011, a Phase IIb, randomized controlled trialMelanie Thompson, Jacob P Lalezari, Richard Kaplan, et al.
AIDS Patient Care and Stds|July 17, 2008
Implementation and evaluation of a clinic-based behavioral intervention: positive steps for patients with HIVLytt I Gardner, Gary Marks, Christine M O'Daniels, et al.
AIDS (London, England)|January 28, 2006
Pharmacokinetics, pharmacodynamics and safety of once-daily versus twice-daily dosing with enfuvirtide in HIV-infected subjectsMelanie Thompson, Edwin DeJesus, Gary Richmond, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2019
Once-daily Doravirine for Initial Treatment of Adults Living With Human Immunodeficiency Virus-1: An Integrated Safety AnalysisMelanie Thompson, Chloe Orkin, Jean-Michel Molina, et al.
AIDS Education and Prevention : Official Publication of the International Society for AIDS Education|February 27, 2009
Improved prevention counseling by HIV care providers in a multisite, clinic-based intervention: Positive STEPsMark Thrun, Paul F Cook, Lucy A Bradley-Springer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2013
Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United StatesAlbert Y Liu, Eric Vittinghoff, Kata Chillag, et al.
AIDS and Behavior|September 19, 2009
Psychosocial characteristics and sexual behaviors of people in care for HIV infection: an examination of men who have sex with men, heterosexual men and womenCarol Golin, Gary Marks, Julie Wright, et al.
AIDS (London, England)|December 31, 2008
Efficacy and safety of etravirine (TMC125) in treatment-experienced HIV-1-infected patients: 48-week results of a phase IIb trialCalvin J Cohen, Daniel S Berger, Gary Blick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2005
Factors that complicate the treatment of tuberculosis in HIV-infected patientsMark S Dworkin, Michael R Adams, David L Cohn, et al.
Journal of the International AIDS Society|November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsJosep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Pageof 6